Chronic pulmonary aspergillosis kills about 80 percent of those suffering from it over five years unless it is treated with long-term antifungals. The European Respiratory Society estimates that 3 million people worldwide have CPA. The infection is particularly difficult to manage and the societies expect these clinical guidelines to be a helpful resource for those treating affected patients.
“This is the first guideline on chronic pulmonary aspergillosis worldwide,” Andrew Ullman, a professor at the Julius Maximilian University of Würzberg and chairman of the ESCMID’s fungal infection study group, said in a statement. “It is the result of another joint effort of ESCMID and ERS experts who, in a truly interdisciplinary collaboration, prepared and published guidance for colleagues on a group of complex diseases that is difficult to manage. Aspergillosis is more than chronic lung infection and a larger document addressing all aspects of aspergillosis infections is under preparation by EFISG.”
More articles on infection control:
CDC: Source of UPMC mold that killed 3 could not be found
FDA relaxes ban on blood donations from gay, bisexual men
WHO publishes list of emerging diseases like to cause major epidemics
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.